Linked Life Data

16794639

Source:http://linkedlifedata.com/resource/pubmed/id/16794639

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
7
pubmed:dateCreated
2006-6-23
pubmed:abstractText
Despite the intense interest in biomarker development for cancer management, few biomarker assays for diagnostic uses have been submitted to the US Food and Drug Administration (FDA). What challenges must researchers overcome to bring cancer-detection technologies to the market and, therefore, into clinical use?
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jul
pubmed:issn
1474-175X
pubmed:author
pubmed:issnType
Print
pubmed:volume
6
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
565-71
pubmed:meshHeading
pubmed:year
2006
pubmed:articleTitle
The US Food and Drug Administration perspective on cancer biomarker development.
pubmed:affiliation
Office of in vitro Diagnostic Devices, Center for Devices and Radiological Health, Food and Drug Administration, NFZ-440, 2098 Gaither Road, Rockville, Maryland 20857, USA. steve.gutman@fda.hhs.gov
pubmed:publicationType
Journal Article, Review